• Immunoassays
  • Flow Cytometry
  • HPLC/LC-MS
  • Antibodies and Antigens
  • Accessories
  • Allergy
  • Bioamines & Neuroscience
  • Bone Metabolism
  • CVD & Oxidative Stress
  • Cytokines & Cell Signaling
  • Diabetes & Obesity
  • Endocrinology
  • Gastroenterology
  • Immunology
  • Infectious Disease
Clinical
Research

Did You Know?

Natriuretic peptides can affect blood pressure

ALPCO is the exclusive North American distributor of Biomedica's proANP and proBNP ELISAs that can be used to assess cardiovascular disease.  [Read more]

Biomarkers of Bone Metabolism

Bone metabolism is a constant battle of bone growth and bone resorption. These two events are carefully orchestrated by several key proteins.  [Read more]

Calprotectin

Inflammatory bowel disease and irritable bowel syndrome exhibit similar symptoms but fecal calprotectin plays a key role in differentiating IBD  [Read more]

Peripheral Neuropathy

Many peripheral neuropathies exhibit similar symptoms.The ganglioside, MAG, and SGPG assays aid in differentiating several neurological disorders  [Read more]

Vitamin D Metabolism and Function

The term "vitamin D" refers to several different forms of this vitamin. Research is focused on the usefulness of vitamin D in various areas.  [Read more]

Biomarkers of Acute Kidney Injury

New biomarkers for renal tissue injury and function have emerged to identify AKI at an earlier stage than traditional methods.  [Read more]

June 13, 2013

ALPCO to Distribute NAG Assays from PPR Diagnostics  [Read more]

May 31, 2013

Mouse Osteopontin ELISA Now Available  [Read more]

May 07, 2013

ALPCO Adds FDA Registered Renin RIA from Cisbio  [Read more]

May 03, 2013

ALPCO Launches Human Osteopontin ELISA  [Read more]

April 30, 2013

ALPCO Adds EuroFlow™ Flow Cytometry Reagents and Infinicyt™ Analyti...  [Read more]

April 26, 2013

ALPCO Launches Their First STELLUX Chemiluminescent ELISA  [Read more]

April 10, 2013

ALPCO Expands Product Offering with Addition of Flow Cytometry Reag...  [Read more]

December 18, 2012

GBC Signs ALPCO as a Distributor in North America  [Read more]

December 12, 2012

ALPCO Diagnostics Recognized by Red Cross for Sandy Relief Efforts  [Read more]

December 11, 2012

ALPCO Diagnostics and BioCat GmbH Sign Exclusive Distribution Agree...  [Read more]

December 07, 2012

ALPCO Diagnostics and Euro Diagnostica Announce Distribution Agreem...  [Read more]

October 05, 2012

ALPCO’s Mouse Sclerostin ELISA to be Featured at ASBMR  [Read more]

July 11, 2012

ALPCO Diagnostics Launches Mouse Sclerostin ELISA  [Read more]

June 27, 2012

ALPCO & Argutus Medical Collaboration  [Read more]

June 19, 2012

Bipartisan Vote Supports Repeal of Device Tax in the House  [Read more]

June 07, 2012

ALPCO Recognized for Support of the American Red Cross 2011 Relief...  [Read more]

March 23, 2012

Detroit R&D and ALPCO Diagnostics Sign Distribution Agreement  [Read more]

February 29, 2012

Increased sclerostin secretion in multiple myeloma results in...  [Read more]

February 15, 2012

Biomedica appoints ALPCO as its Exclusive Distributor in Canada  [Read more]

February 08, 2012

Estimated cost reductions in colonoscopies using Calprototectin  [Read more]

January 18, 2012

Fecal Calprotectin for differentiating IBD vs. IBS  [Read more]

January 09, 2012

Pancreatic β-Cell research associated with metabolic ... (Continued...  [Read more]

November 18, 2011

Abstract from Leukemia & Lymphoma  [Read more]

September 15, 2011

Research validates the accuracy of the biomarker fecal Calprotectin  [Read more]

August 18, 2011

Yale research finds predictors of kidney damage post-cardiac surger...  [Read more]

July 15, 2011

New Biomarker Test Allows Early Detection Of Adverse Prognosis Afte...  [Read more]

July 10, 2011

ALPCO Appoints CST China as Their Exclusive Distributor in China.  [Read more]

July 05, 2011

ALPCO Diagnostics' partnership with Electra-Box Diagnostica AB look...  [Read more]